Drugs News and Research

RSS

Long-standing immunosuppressive drug reduces Zika birth defects in mice

In experiments with pregnant mice infected with the Zika virus, Johns Hopkins Medicine researchers report they have successfully used a long-standing immunosuppressive drug to diminish the rate of fetal deaths and birth defects in the mice's offspring.

From Johns Hopkins Medicine 7 May 2019

Researchers develop new molecule that binds to the cerebrovascular system

Brazilian and US researchers have developed a molecule called FRW that, in tests with mice, proved capable of binding to blood vessels in the brain but not in other organs when injected into the bloodstream.

7 May 2019

Research into cancer signaling network reveals new roadmap to tumor control

In this advanced age of molecular sleuthing, a research team led by Georgetown Lombardi Comprehensive Cancer Center have findings that suggest tumors will eventually become resistant to drug inhibitors of a common cancer pathway (dubbed YAP/TAZ), now in preclinical development.

7 May 2019

Researchers develop a new approach to targeting tumors and metastases

The spread of malignant cells from an original tumor to other parts of the body, known as metastasis, is the main cause of cancer deaths worldwide.

7 May 2019

Novel bioinformatics tool improves gene identification

Like finding a needle in a haystack, identifying genes that are involved in particular diseases can be an arduous and time consuming process.

6 May 2019

Form drives function in cancer proliferation, UTSW study finds

A new study finds that the protein responsible for the crawling movements of cells also drives the ability of cancer cells to grow when under stress.

6 May 2019

Quanterix’ Simoa technology powers more than 85 percent of Neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting

Quanterix announce that its ultra-sensitive Simoa technology is the driving force behind 36 of the 42 Nf-L abstracts being presented at AANA.

From Quanterix 6 May 2019

Aptamer Therapeutics collaborates with Cancer Research UK for drug development program

Following the successful awarding of a CRUK Biotherapeutic Drug Discovery Project Award, Aptamer Therapeutics Limited, part of Aptamer Group, is pleased to announce a new collaboration with Dan Wiseman and the Oglesby Leukemia Research Program at the University of Manchester and Cancer Research UK.

From Aptamer Group 6 May 2019

Researchers develop smart pill bottle to keep drugs safe

Low-cost, stretchy sensors can be assembled inside the lid of a drug container to help monitor patient safety.

6 May 2019

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

According to a new research, circulating tumor DNA can be used detect treatment options for ovarian cancer patients who don't benefit from chemotherapy.

6 May 2019

Many patients and the public have low awareness of heart failure

Low awareness of heart failure among patients and the public is highlighted in surveys to be presented during Heart Failure 2019 the annual congress of the Heart Failure Association, a branch of the European Society of Cardiology, taking place in Athens, Greece from 25 to 28 May.

6 May 2019

Innovative 'gut-on-a-chip' technology will help better understand Crohn's disease

To model human health and disease, organ-on-a-chip technology mimics the human body's organ structure, functionality and physiology in a controlled environment.

3 May 2019

New two-tier method can enable early-stage detection of Alzheimer’s

Using current techniques, Alzheimer's disease, the most frequent cause of dementia, can only be detected once the typical plaques have formed in the brain.

3 May 2019

Experts to present tumor DNA, breast and jaw reconstruction studies at PSRC annual meeting

The Plastic Surgery Research Council focuses on awareness surrounding compelling research relating to the field of plastic surgery.

3 May 2019

New insight into fast-growing retail and medicinal cannabis industry

Edison Group, the leading investment and research advisory company, has published its sector report analyzing the growing retail and medicinal cannabis industry.

3 May 2019

Scientists unravel mechanism of action of antitumor drug used to treat glioblastoma

Glioblastoma is an incurable type of brain tumor that is frequently associated with mutations in the epidermal growth factor receptor.

3 May 2019

Finnish researchers discover gene mutation that reduces fear, anxiety and increases social interaction

Finnish researchers at the University of Eastern Finland and the University of Oulu have discovered of a new type of gene mutation that reduces fear and anxiety, and increases social interaction.

3 May 2019

New method could lead to more personalized treatment of advanced prostate cancer

Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer.

3 May 2019

Research on Reddit identifies risks associated with unproven treatments for opioid addiction

Using advanced machine-learning techniques, Georgia Tech researchers have examined nearly 1.5 million Reddit posts to identify risks associated with several of the most common alternative - and unproven - "treatments" for opioid addiction.

2 May 2019

Researchers examine coatings of drug-coated balloon catheters at microscopic levels

Drug-coated balloon catheters to open narrowed blood vessels and to deliver drugs to the impacted sites are used frequently for the treatment of peripheral arterial disease.

2 May 2019

Drugs News and Research

Long-standing immunosuppressive drug reduces Zika birth defects in mice

Researchers develop new molecule that binds to the cerebrovascular system

Research into cancer signaling network reveals new roadmap to tumor control

Researchers develop a new approach to targeting tumors and metastases

Novel bioinformatics tool improves gene identification

Form drives function in cancer proliferation, UTSW study finds

Quanterix’ Simoa technology powers more than 85 percent of Neurofilament light biomarker research to be unveiled at American Academy of Neurology Annual Meeting

Aptamer Therapeutics collaborates with Cancer Research UK for drug development program

Researchers develop smart pill bottle to keep drugs safe

Circulating tumor DNA can help detect treatment options for ovarian cancer subtype

Many patients and the public have low awareness of heart failure

Innovative 'gut-on-a-chip' technology will help better understand Crohn's disease

New two-tier method can enable early-stage detection of Alzheimer’s

Experts to present tumor DNA, breast and jaw reconstruction studies at PSRC annual meeting

New insight into fast-growing retail and medicinal cannabis industry

Scientists unravel mechanism of action of antitumor drug used to treat glioblastoma

Finnish researchers discover gene mutation that reduces fear, anxiety and increases social interaction

New method could lead to more personalized treatment of advanced prostate cancer

Research on Reddit identifies risks associated with unproven treatments for opioid addiction

Researchers examine coatings of drug-coated balloon catheters at microscopic levels

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News